Mozambique - Prevalence of HIV, total (% of population ages 15-49)

Prevalence of HIV, total (% of population ages 15-49) in Mozambique was 11.50 as of 2020. Its highest value over the past 30 years was 12.00 in 2016, while its lowest value was 1.20 in 1990.

Definition: Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.

Source: UNAIDS estimates.

See also:

Year Value
1990 1.20
1991 1.60
1992 2.10
1993 2.70
1994 3.40
1995 4.10
1996 4.90
1997 5.80
1998 6.70
1999 7.60
2000 8.50
2001 9.20
2002 9.90
2003 10.40
2004 10.80
2005 11.00
2006 11.20
2007 11.40
2008 11.50
2009 11.70
2010 11.80
2011 11.90
2012 11.90
2013 12.00
2014 12.00
2015 12.00
2016 12.00
2017 11.90
2018 11.80
2019 11.70
2020 11.50

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Risk factors